Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-132,045
Closed -$16.4M 321
2021
Q2
$16.4M Sell
132,045
-31,447
-19% -$3.95M 0.7% 35
2021
Q1
$19.3M Sell
163,492
-20,082
-11% -$2.35M 0.68% 44
2020
Q4
$21.5M Sell
183,574
-50,031
-21% -$5.51M 0.65% 42
2020
Q3
$24.2M Buy
233,605
+103,405
+79% +$10.4M 0.59% 39
2020
Q2
$11.9M Sell
130,200
-29,800
-19% -$2.86M 0.44% 48
2020
Q1
$14.5M Buy
160,000
+22,100
+16% +$2.35M 0.62% 36
2019
Q4
$15.6M Hold
137,900
0.53% 43
2019
Q3
$15M Buy
137,900
+2,900
+2% +$303K 0.55% 37
2019
Q2
$13.1M Sell
135,000
-9,000
-6% -$822K 0.49% 45
2019
Q1
$13.1M Hold
144,000
0.51% 47
2018
Q4
$13.1M Sell
144,000
-24,000
-14% -$2.24M 0.54% 42
2018
Q3
$16.5M Buy
168,000
+16,000
+11% +$1.48M 0.51% 47
2018
Q2
$13M Hold
152,000
0.42% 58
2018
Q1
$12.2M Hold
152,000
0.44% 55
2017
Q4
$12.3M Sell
152,000
-6,000
-4% -$481K 0.44% 49
2017
Q3
$12.3M Hold
158,000
0.44% 56
2017
Q2
$14M Sell
158,000
-15,000
-9% -$1.26M 0.51% 47
2017
Q1
$13.9M Buy
173,000
+71,000
+70% +$5.55M 0.53% 47
2016
Q4
$7.27M Sell
102,000
-70,000
-41% -$5.5M 0.27% 98
2016
Q3
$14.9M Sell
172,000
-64,000
-27% -$5.58M 0.57% 43
2016
Q2
$20.5M Buy
236,000
+51,000
+28% +$4.12M 0.82% 23
2016
Q1
$13.9M Buy
185,000
+20,000
+12% +$1.51M 0.56% 52
2015
Q4
$12.7M Hold
165,000
0.52% 59
2015
Q3
$11M Sell
165,000
-103,000
-38% -$7.59M 0.5% 67
2015
Q2
$19.9M Sell
268,000
-83,680
-24% -$6.39M 0.75% 33
2015
Q1
$27.4M Sell
351,680
-3,320
-0.9% -$252K 0.87% 19
2014
Q4
$25.6M Buy
355,000
+58,000
+20% +$4.03M 0.65% 25
2014
Q3
$18.4M Buy
297,000
+27,000
+10% +$1.72M 0.53% 32
2014
Q2
$17.2M Buy
270,000
+160,000
+145% +$9.72M 0.54% 30
2014
Q1
$6.77M Buy
110,000
+10,000
+10% +$582K 0.23% 113
2013
Q4
$5.74M Hold
100,000
0.21% 123
2013
Q3
$5.33M Hold
100,000
0.32% 113
2013
Q2
$5.15M Buy
+100,000
New +$4.94M 0.31% 110

Other funds holding MDT

BP's MDT Position: Q3 2021 in Review

BP sold out of Medtronic (MDT) in Q3 2021, closing a stake of 132,045 shares — an estimated $16.4M sold.

BP first reported a position in MDT in Q2 2013 and held it in 33 quarters. The position peaked at $27.4M in Q1 2015. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • BP reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • BP sold 132,045 Medtronic shares in Q3 2021, an estimated $16.4M.
  • BP first reported a position in Medtronic in Q2 2013 and held it in 33 quarters.
  • BP's Medtronic position peaked at $27.4M in Q1 2015.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.